Infinitopes raised £12.8 million seed led by Octopus Ventures, joined by Kindred Capital, Manta Ray, Martlet Capital, Meltwind, Saras Capital and Wilbe.

Health services Manufacturing Pharma

Investments

01 April 2024

Infinitopes (company)

Health services Manufacturing Pharma

Total investments received (USD): 31.41m

Round value (USD): 16.01m

Round investors: Kindred Capital Manta Ray Martlet Capital Meltwind Octopus Ventures Wilbe Capital Saras Capital Cancer Research Horizons CRIS Cancer Foundation

Company: Infinitopes

Industry: Health services Manufacturing Pharma

Related deals

LIfT BioSciences in a £10M series A deal with Sijbrandij Foundation, Lifespan Vision Ventures, Starbloom Capital and Jonathan Milner.

Biotech Health services Manufacturing

Investments 15 September 2024

Epsilogen to raise £12.5M in a series B extension

Biotech Health services Manufacturing

Investments 29 August 2024

Hexarad raised €13 million in a funding round led by MTIP, joined by investors including Foresight Group.

Health services Manufacturing

Investments 02 August 2024

EpilepsyGTx raised $10 million in a seed round led by the UCL Technology Fund, with participation from Health Technology Holding.

Biotech Health services Pharma

Investments 19 June 2024

Oxford Endovascular raised £8m Series A led by Parkwalk Advisors, joined by Norcliffe Capital, The Uni of Oxford, Oxford Science Enterprises, and Vulpes IM.

Biotech Hardware Health services Manufacturing

Investments 02 May 2024

Menu

Infinitopes raised £12.8 million seed led by Octopus Ventures, joined by Kindred Capital, Manta Ray, Martlet Capital, Meltwind, Saras Capital and Wilbe.

Share:

Infinitopes (company)

Related deals

LIfT BioSciences in a £10M series A deal with Sijbrandij Foundation, Lifespan Vision Ventures, Starbloom Capital and Jonathan Milner.

Epsilogen to raise £12.5M in a series B extension

Hexarad raised €13 million in a funding round led by MTIP, joined by investors including Foresight Group.

EpilepsyGTx raised $10 million in a seed round led by the UCL Technology Fund, with participation from Health Technology Holding.

Oxford Endovascular raised £8m Series A led by Parkwalk Advisors, joined by Norcliffe Capital, The Uni of Oxford, Oxford Science Enterprises, and Vulpes IM.

Sidebar

Verticals

Benelux

DACH

Nordics and Baltics

Western Europe